E-Articles - Health and Fitness

You may have read of the link between heartburn and squamous cell/other esophagea

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

l cancers.

The relationship is a complex one that has changed over the years. Wh

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

ereas decades ago, most esophageal cancers were of the squamous cell variety, tod

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

ay the vast majority of cancers of the esophagus are not squamous carcinomas but

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

adenocarcinomas.

In fact, a stronger link has been found between development of

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

adenocarcinomas and a history of GERD or acid reflux -- these are conditions of l

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

ong term and frequent heartburn symptoms due to inefficiencies in the lower esoph

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

ageal sphincter or valve when stomach acid is allowed to escape its normal home i

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

nto the esophagus.

Also, squamous cell cancers are much more prevalent in partic

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

ular ethnic groups, for instance black versus white ethnic groups.

Squamous cell

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

cancers have long been linked with damaging lifestyles involving smoking and alco

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

hol abuse. It is widely known that these lifestyles are more likely to give rise

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

to heartburn. Therefore, it seems logical that a high frequency of reported heart

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

burn and squamous cell carcinomas would go hand in hand.

The findings from studi

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

es looking into the relationship between heartburn and squamous cell cancers are

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

largely mixed, however. For instance, this cancer has reached epidemic proportion

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

s in Africa in the past few years thought to be due to diet. However, this diet r

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

esults in reflux of a low acidity. So, whilst the symptoms of heartburn and squam

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

ous cell cancers have been observed together, the low acidity of the reflux gives

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

more food for thought and much research is still needed in this area of medicine

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.e-article.org.ua/article/241481/e-article-Heartburn-And-Squamous-Cell-Cancers--Is-There-A-Link.html">Heartburn And Squamous Cell Cancers - Is There A Link?</a>

BB link (for phorums):
[url=http://www.e-article.org.ua/article/241481/e-article-Heartburn-And-Squamous-Cell-Cancers--Is-There-A-Link.html]Heartburn And Squamous Cell Cancers - Is There A Link?[/url]

Wouldn't it be nice to be able to eat that management elephant one bite at a time so that you could truly know that you are going to increase your management wins? These 7 strategies may help you do just that.

DENIC, the registry of the German Top Level Domain (TLD) has announced, that it has received the eight millionth application for the registration of a de-domain. The de-domain has the position as t...

Speed reading is a necessity, a skill that is needed to compete in this modern world, when information intake is a significant advantage in any job requirement. Many people believe that in order to improve their reading skills they should focus on reading speed increase in order to improve their reading skills.

Tags

Links

E-Articles - Heartburn And Squamous Cell Cancers - Is There A Link?

Related Articles: